These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14715714)

  • 1. Mice deficient in 11beta-hydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation.
    Justesen J; Mosekilde L; Holmes M; Stenderup K; Gasser J; Mullins JJ; Seckl JR; Kassem M
    Endocrinology; 2004 Apr; 145(4):1916-25. PubMed ID: 14715714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
    Cooper MS; Rabbitt EH; Goddard PE; Bartlett WA; Hewison M; Stewart PM
    J Bone Miner Res; 2002 Jun; 17(6):979-86. PubMed ID: 12054173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy.
    Fenton CG; Doig CL; Fareed S; Naylor A; Morrell AP; Addison O; Wehmeyer C; Buckley CD; Cooper MS; Lavery GG; Raza K; Hardy RS
    Arthritis Res Ther; 2019 Aug; 21(1):188. PubMed ID: 31420008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye.
    Onyimba CU; Vijapurapu N; Curnow SJ; Khosla P; Stewart PM; Murray PI; Walker EA; Rauz S
    J Endocrinol; 2006 Aug; 190(2):483-93. PubMed ID: 16899581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo.
    De Sousa Peixoto RA; Turban S; Battle JH; Chapman KE; Seckl JR; Morton NM
    Endocrinology; 2008 Apr; 149(4):1861-8. PubMed ID: 18174284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 11β-HSD1 dehydrogenase activity on bone histomorphometry of glucocorticoid-induced osteoporotic male Sprague-Dawley rats.
    Elvy Suhana MR; Farihah HS; Faizah O; Nazrun AS; Norazlina M; Norliza M; Ima-Nirwana S
    Singapore Med J; 2011 Nov; 52(11):786-93. PubMed ID: 22173247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells.
    Bujalska IJ; Walker EA; Hewison M; Stewart PM
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1205-10. PubMed ID: 11889189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone.
    Cooper MS; Blumsohn A; Goddard PE; Bartlett WA; Shackleton CH; Eastell R; Hewison M; Stewart PM
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3874-7. PubMed ID: 12915682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities.
    Zhang TY; Ding X; Daynes RA
    J Immunol; 2005 Jan; 174(2):879-89. PubMed ID: 15634910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages from 11beta-hydroxysteroid dehydrogenase type 1-deficient mice exhibit an increased sensitivity to lipopolysaccharide stimulation due to TGF-beta-mediated up-regulation of SHIP1 expression.
    Zhang TY; Daynes RA
    J Immunol; 2007 Nov; 179(9):6325-35. PubMed ID: 17947710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable expression of 11beta Hydroxysteroid dehydrogenase (11beta-HSD) isoforms in vascular endothelial cells.
    Gong R; Morris DJ; Brem AS
    Steroids; 2008 Oct; 73(11):1187-96. PubMed ID: 18573267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes.
    Tagawa N; Yuda R; Kubota S; Wakabayashi M; Yamaguchi Y; Kiyonaga D; Mori N; Minamitani E; Masuzaki H; Kobayashi Y
    J Endocrinol; 2009 Jul; 202(1):131-9. PubMed ID: 19380458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response.
    Chapman KE; Coutinho A; Gray M; Gilmour JS; Savill JS; Seckl JR
    Ann N Y Acad Sci; 2006 Nov; 1088():265-73. PubMed ID: 17192572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
    Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
    J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11β-Hydroxysteroid Dehydrogenase Type 1 within Osteoclasts Mediates the Bone Protective Properties of Therapeutic Corticosteroids in Chronic Inflammation.
    Fenton CG; Crastin A; Martin CS; Suresh S; Montagna I; Hussain B; Naylor AJ; Jones SW; Hansen MS; Gorvin CM; Price M; Filer A; Cooper MS; Lavery GG; Raza K; Hardy RS
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11β-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI.
    Mylonas KJ; Turner NA; Bageghni SA; Kenyon CJ; White CI; McGregor K; Kimmitt RA; Sulston R; Kelly V; Walker BR; Porter KE; Chapman KE; Gray GA
    J Endocrinol; 2017 Jun; 233(3):315-327. PubMed ID: 28522730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid.
    Diederich S; Quinkler M; Mai K; Schöneshöfer M; Baehr V; Pfeiffer A; Oelkers W; Eigendorff E
    Horm Metab Res; 2011 Jan; 43(1):66-71. PubMed ID: 20925019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
    Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
    J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
    Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
    Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
    Tomlinson JW; Stewart PM
    Horm Metab Res; 2002; 34(11-12):746-51. PubMed ID: 12660893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.